These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 3225768)

  • 1. Effect of salicylate on serum protein binding and red blood cell uptake of acetazolamide in vitro.
    Sweeney KR; Chapron DJ; Kramer PA
    J Pharm Sci; 1988 Sep; 77(9):751-6. PubMed ID: 3225768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxic interaction between acetazolamide and salicylate: case reports and a pharmacokinetic explanation.
    Sweeney KR; Chapron DJ; Brandt JL; Gomolin IH; Feig PU; Kramer PA
    Clin Pharmacol Ther; 1986 Nov; 40(5):518-24. PubMed ID: 3769383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Uptake of acetazolamide by human erythrocytes in vitro.
    Wallace SM; Reigelman S
    J Pharm Sci; 1977 May; 66(5):729-31. PubMed ID: 874760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elucidating the relationship between acetazolamide plasma protein binding and renal clearance using an albumin infusion.
    Gomolin IH; Chapron DJ
    J Clin Pharmacol; 1992 Nov; 32(11):1028-32. PubMed ID: 1474164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central nervous system salicylate.
    Reed JR; Palmisano PA
    Clin Toxicol; 1975; 8(6):623-31. PubMed ID: 6188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in (a-ET) PCO2 produced by acetazolamide in red cells, not in plasma].
    Taki K; Takahashi N; Mizuno K; Fujiwara K
    Kokyu To Junkan; 1989 Aug; 37(8):879-83. PubMed ID: 2515566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Salicylate clearance, the resultant of protein binding and metabolism.
    Furst DE; Tozer TN; Melmon KL
    Clin Pharmacol Ther; 1979 Sep; 26(3):380-9. PubMed ID: 466931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of advanced age on the disposition of acetazolamide.
    Chapron DJ; Sweeney KR; Feig PU; Kramer PA
    Br J Clin Pharmacol; 1985 Mar; 19(3):363-71. PubMed ID: 3986087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Binding of 8-methoxypsoralen to human serum proteins and red blood cells.
    Pibouin M; Zini R; Nguyen P; Renouard A; Tillement JP
    Br J Dermatol; 1987 Aug; 117(2):207-15. PubMed ID: 3651341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acetazolamide binding to two carbonic anhydrase isoenzymes in human erythrocytes.
    Bayne WF; Chu LC; Theeuwes F
    J Pharm Sci; 1979 Jul; 68(7):912-3. PubMed ID: 110919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum protein binding of salicylate during pregnancy and the puerperium.
    Lovecchio JL; Krasner J; Yaffe SJ
    Dev Pharmacol Ther; 1981; 2(3):172-9. PubMed ID: 7227142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fate of [14C]warfarin in guinea-pigs: effect of a concomitant single dose of salicylate.
    Wong LT; Solomonraj G; Thomas BH
    J Pharm Pharmacol; 1978 Apr; 30(4):240-3. PubMed ID: 24713
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relation between net calcium, alkali cation and chloride movements in red cells exposed to salicylate.
    Bürgin H; Schatzmann HJ
    J Physiol; 1979 Feb; 287():15-32. PubMed ID: 430388
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats.
    Yu HY; Shen YZ; Sugiyama Y; Hanano M
    Drug Metab Dispos; 1990; 18(1):121-6. PubMed ID: 1970771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.
    Netter P; Monot C; Stalars MC; Mur JM; Royer RJ; Faure G; Pourel J; Martin J; Gaucher A
    Eur J Drug Metab Pharmacokinet; 1984; 9(2):109-16. PubMed ID: 6745302
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salicylate protein binding in serum from young and elderly subjects as measured by diafiltration.
    Lesko LJ; Narang PK; Yeager L; Cutler NR
    Eur J Clin Pharmacol; 1985; 28(3):339-45. PubMed ID: 4007039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CO2 retention as a basis for increased toxicity of salicylate with acetazolamide: avoidance of increased toxicity with benzolamide.
    Liddell NE; Maren TH
    J Pharmacol Exp Ther; 1975 Oct; 195(1):1-7. PubMed ID: 241836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired plasma protein binding of phenytoin in uremia and displacement effect of salicylic acid.
    Odar-Cederlöf I; Borga O
    Clin Pharmacol Ther; 1976 Jul; 20(1):36-47. PubMed ID: 1277724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetazolamide blood concentrations are excessive in the elderly: propensity for acidosis and relationship to renal function.
    Chapron DJ; Gomolin IH; Sweeney KR
    J Clin Pharmacol; 1989 Apr; 29(4):348-53. PubMed ID: 2498399
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma protein binding and interaction studies with diflunisal, a new salicylate analgesic.
    Verbeeck RK; Boel A; Buntinx A; De Schepper PJ
    Biochem Pharmacol; 1980 Feb; 29(4):571-6. PubMed ID: 7370051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.